SCM
EDIT icon

Sio Capital Management’s Editas Medicine EDIT Stock Holding History

Sio Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,714
Closed -$266K – 45
2016
Q1 		$266K Buy
+7,714
New +$203K 0.1% 40

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Sio Capital Management's EDIT Position: Q2 2016 in Review

Sio Capital Management sold out of Editas Medicine (EDIT) in Q2 2016, closing a stake of 7,714 shares — an estimated $266K sold.

Sio Capital Management first reported a position in EDIT in Q1 2016 and held it in 1 quarter. The position peaked at $266K in Q1 2016. 68 funds tracked by Wall St. Rank hold EDIT as of Q2 2016.

  • Sio Capital Management reported no remaining Editas Medicine position as of Q2 2016 after selling out during the quarter.
  • Sio Capital Management sold 7,714 Editas Medicine shares in Q2 2016, an estimated $266K.
  • Sio Capital Management first reported a position in Editas Medicine in Q1 2016 and held it in 1 quarter.
  • Sio Capital Management's Editas Medicine position peaked at $266K in Q1 2016.
  • 68 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2016.

Based on Sio Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.